Ludovic Evesque

2.8k citations

57 papers · 1.1k indexed · 2 hit papers · h-index 14

Impact in

Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research

Papers in ⓘ

Oncology 41
- Colorectal Cancer Treatments and Studies 21
- Colorectal Cancer Surgical Treatments 11
- Pancreatic and Hepatic Oncology Research 9
Gastroenterology 6
- Gastrointestinal Tumor Research and Treatment 6

Co-authors: Lucjan Wyrwicz (4 shared papers)Narikazu Boku (3 shared papers)Min‐Hee Ryu (3 shared papers)Michael Schenker (3 shared papers)Julien Taı̈eb (4 shared papers)Yu Jeong Bang (1 shared paper)Kuhn‐Uk Lee (1 shared paper)Hyun Cheol Chung (1 shared paper)
Journals: Annals of Oncology (13 papers)Journal of Clinical Oncology (12 papers)European Journal of Cancer (3 papers)Clinical Colorectal Cancer (2 papers)Gastroenterology (2 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Ludovic Evesque

46 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial 2024 · 57 citations

Peers

Countries citing papers authored by Ludovic Evesque

Since Specialization

Citations

This map shows the geographic impact of Ludovic Evesque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Evesque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Evesque more than expected).

Fields of papers citing papers by Ludovic Evesque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovic Evesque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Evesque. The network helps show where Ludovic Evesque may publish in the future.

Co-authors

The 25 scholars most cited alongside Ludovic Evesque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ludovic Evesque Line = papers co-authored together Ludovic Evesque links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 Annals of Oncology ·Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem, Kuhn‐Uk Lee, Lucjan Wyrwicz, Michael Schenker, María Alsina, Min‐Hee Ryu, Hyun Cheol Chung, Ludovic Evesque, Salah-Eddin Al-Batran, Se Hoon Park, M. Lichinitser, Narikazu Boku, Markus Moehler, Janet Hong, Hua Xiong, Roland Hallwachs, Ilaria Conti, Julien Taı̈eb Hit paper breakdown →	2018	372
2	A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization The American Journal of Gastroenterology ·Abderrahim Oussalah, Ludovic Evesque, David Laharie, Xavier Roblin, Gilles Boschetti, Stéphane Nancey, Jérôme Filippi, Bernard Flourié, Xavier Hébuterne, Marc‐André Bigard, Laurent Peyrin‐Biroulet	2010	146
3	Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial. Journal of Clinical Oncology ·Thierry Conroy, Pierre-Luc Etienne, Emmanuel Rio, Ludovic Evesque, Nathalie Mesgouez‐Nebout, V. Vendrely, Xavier Artignan, Olivier Bouché, Alice Boilève, Matthieu Delaye, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Christelle de la Fouchardière, Clotilde Morand, Veronica Pezzella, Éric Rullier, Florence Castan, Christophe Borg	2023	64
4	Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial Annals of Oncology ·Thierry Conroy, Florence Castan, Pierre-Luc Etienne, E. Rio, Nathalie Mesgouez‐Nebout, Ludovic Evesque, V. Vendrely, Xavier Artignan, Olivier Bouché, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Alice Boilève, Matthieu Delaye, Sophie Gourgou, Veronica Pezzella, Christophe Borg Hit paper breakdown →	2024	57
5	Effect of Detoxification on Liver Stiffness Assessed by Fibroscan® in Alcoholic Patients Alcoholism Clinical and Experimental Research ·Ève Gelsi, Raphaella Dainese, Régine Truchi, Eugènia Mariné–Barjoan, Rodolphe Anty, Michèle Autuori, Sonia Burroni, Geoffroy Vanbiervliet, Ludovic Evesque, Faredj Chérikh, Albert Tran	2010	48
6	Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens Annals of Oncology ·Yoon‐Koo Kang, W. Kang, Maria Di Bartolomeo, Ian Chau, Harry H. Yoon, Stefano Cascinu, Min‐Hee Ryu, J.G. Kim, K.-W. Lee, Sang Cheul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Vladimir Vladimirov, Ludovic Evesque, Michael Schenker, Aileen McGinn, Neil Sankar, Lucjan Wyrwicz, Narikazu Boku	2019	47
7	Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study European Journal of Cancer ·Jean‐Pierre Gérard, N. Barbet, Jocelyn Gal, C. Dejean, Ludovic Evesque, J. Doyen, R. Coquard, Jean Gugenheim, Emmanuel Benizri, Renaud Schiappa, G. Baudin, K. Bénézéry, Éric François	2018	44
8	Radiosensitivity of Colon and Rectal Lung Oligometastasis Treated With Stereotactic Ablative Radiotherapy Clinical Colorectal Cancer ·Rémy Kinj, Pierre‐Yves Bondiau, Éric François, Jean‐Pierre Gérard, A.O. Naghavi, Axel Leysalle, Emmanuel Chamorey, Ludovic Evesque, B. Padovani, Antoine Ianessi, Karen Bénézery, J. Doyen	2016	31
9	Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients European Journal of Cancer ·Anne Claire Frin, Ludovic Evesque, Jocelyn Gal, K. Bénézéry, Éric François, Jean Gugenheim, Emmanuel Benizri, Yan Château, S. Marcié, J. Doyen, Jean‐Pierre Gérard	2016	29
10	Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX Oncology ·Juliette Reure, Philippe Follana, Jocelyn Gal, Ludovic Evesque, Gérard Cavaglione, Angélique Saint, E. François	2016	18
11	Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer International Journal of Cancer ·Cindy Neuzillet, Andrea Casadei‐Gardini, Bertrand Brieau, Caterina Vivaldi, Giovanni Brandi, David Tougeron, Roberto Filippi, Angélique Vienot, Nicola Silvestris, Anne‐Laure Pointet, Sara Lonardi, Benoı̂t Rousseau, Mario Scartozzi, Laëtitia Dahan, Giuseppe Aprile, Samuel Le Sourd, Ludovic Evesque, Aurélia Meurisse, Astrid Lièvre, Déwi Vernerey, (unknown)	2020	17
12	Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial Digestive and Liver Disease ·Julien Taı̈eb, Thierry André, Farid El Hajbi, Emilie Barbier, Clémence Toullec, Stéfano Kim, Olivier Bouché, Frédéric Di Fiore, Marion Chauvenet, Hervé Perrier, Ludovic Evesque, Pierre Laurent‐Puig, Jean‐François Emile, Jérémie Bez, Côme Lepage, David Tougeron	2020	17
13	Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience Diseases of the Colon & Rectum ·Ludovic Evesque, Karen Bénézery, Philippe Follana, Alexander T. Falk, J. Doyen, Juliette Reure, Gérard Cavaglione, Éric François	2017	16
14	Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence Clinical and Translational Radiation Oncology ·Karen Bénézery, Lucile Montagné, Ludovic Evesque, Renaud Schiappa, Jean‐Michel Hannoun‐Lévi, Éric François, Brice Thamphya, Jean‐Pierre Gérard	2020	14
15	Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer. Journal of Clinical Oncology ·Mohamed Bouattour, Juan W. Valle, Arndt Vogel, Jin Won Kim, Masayuki Kitano, Jen‐Shi Chen, Howard A. Burris, Renata Zaucha, Shukui Qin, Ludovic Evesque, David B. Zhen, Vineet Gupta, Joon Oh Park, Magdalena Żotkiewicz, Nana Rokutanda, Gordon Cohen, Do‐Youn Oh	2023	13
16	Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study Supportive Care in Cancer ·Angélique Saint, J. Viotti, Delphine Borchiellini, Benjamin Hoch, Vittoria Raimondi, Christophe Hébert, R. Largillier, Ludovic Evesque, Philippe Follana, Jean-Marc Ferrero, Constance Delaby, Renaud Schiappa, Emmanuel Chamorey, Jérôme Barrière	2019	10
17	Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series European Journal of Cancer ·Émilie Hafliger, Alessandra Boccaccino, Alexandra Lapeyre-Prost, Audrey Perret, Claire Gallois, Maria Antista, Lorenzo Pilla, Thierry Lecomte, Mario Scartozzi, Émilie Soularue, Lisa Salvatore, Vincent Bourgeois, Massimiliano Salati, David Tougeron, Ludovic Evesque, Jean-Nicolas Vaillant, Reem El-Khoury, Sara Lonardi, Chiara Cremolini, Julien Taı̈eb	2022	8
18	Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: A multicenter AGEO study. Journal of Clinical Oncology ·Juliette Palle, David Tougeron, Astrid Pozet, Émilie Soularue, Pascal Artru, Florence Le Roy, Olivier Dubreuil, Matthieu Sarabi, Nicolas Williet, Sylvain Manfrédi, J. Martin-Babau, Christine Rebischung, Méher Ben Abdelghani, Ludovic Evesque, Johann Dréanic, Vincent Hautefeuille, Christophe Louvet, Thierry Lecomte, Julien Taı̈eb, Aziz Zaanan	2017	8
19	397MO Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in HER2-negative advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma (GC/GEJC): PD-L1 biomarker analysis from RATIONALE-305 Annals of Oncology ·Markus Moehler, D-Y. Oh, Kazuyoshi Kato, Josep Tabernero, Marcia Cruz‐Correa, Lucjan Wyrwicz, Roberto Pazo-Cid, A. Cubillo, Ludovic Evesque, Lorenzo Fornaro, Eden Dotan, Carys Morgan, L. Li, Yaling Xu, Tao Sheng, Shu‐Hua Yang, Hong Hu, R-H. Xu	2024	7
20	Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial Gastric Cancer ·Yoon‐Koo Kang, Min‐Hee Ryu, Maria Di Bartolomeo, Ian Chau, Harry H. Yoon, Jong Gwang Kim, Keun‐Wook Lee, Sang Chul Oh, Atsuo Takashima, Anna Kryzhanivska, Yee Chao, Ludovic Evesque, Michael Schenker, Arlo N. McGinn, Zhao Yu-fan, Jennifer Lee, Lucjan Wyrwicz, Narikazu Boku	2024	7

About Ludovic Evesque

Ludovic Evesque is a scholar working on Oncology, Gastroenterology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 57 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Colorectal and Anal Carcinomas (19 papers), Gastric Cancer Management and Outcomes (19 papers), Colorectal Cancer Surgical Treatments (11 papers), Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Sarcoma Diagnosis and Treatment (7 papers) and Gastrointestinal Tumor Research and Treatment (6 papers). The work is most often cited by research in Gastroenterology (155 citations), Oncology (648 citations), Pulmonary and Respiratory Medicine (449 citations), Hepatology (92 citations) and Surgery (447 citations). Ludovic Evesque has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Lucjan Wyrwicz, Narikazu Boku, Min‐Hee Ryu, Michael Schenker, Julien Taı̈eb, Yu Jeong Bang, Kuhn‐Uk Lee, Hyun Cheol Chung, Hua Xiong and Eduardo Yañez Ruiz. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, Clinical Colorectal Cancer and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact